|
UCB Group (*) |
First half-year period |
Variation | ||
|
(in € million) |
2003 |
2004 |
In real
terms |
At
constant
exchange
rates |
|
|
|
| ||
|
Turnover |
1,512.4 |
1,536.0 |
+2% |
+6% |
|
Pharma |
738.7 |
784.2 |
|
|
|
Surface Specialties |
773.0 |
750.4 |
|
|
|
- Films |
185.5 |
181.4 |
|
|
|
Non sectorial |
0.7 |
1.4 |
|
|
|
|
|
|
|
|
|
Operating profit (EBIT) |
233.7 |
257.4 |
|
|
|
Net financial costs |
-5.3 |
0.7 |
|
|
|
|
|
|
|
|
|
Ordinary profit |
228.4 |
258.1 |
+13% |
+25% |
|
Pharma |
192.8 |
200.9 |
+ 4% |
+16% |
|
Surface Specialties |
30.8 |
50.4 |
+64% |
+79% |
|
- Films |
0.4 |
1.7 |
|
|
|
Non sectorial |
4.8 |
6.8 |
|
|
|
|
|
|
|
|
|
Extraordinary profit |
-31.1 |
1.9 |
|
|
|
Pharma |
-2.1 |
5.7 |
|
|
|
Surface Specialties |
-21.5 |
-7.9 |
|
|
|
Non sectorial |
-7.5 |
4.1 |
|
|
|
|
|
|
|
|
|
Tax |
-61.2 |
-78.0 |
|
|
|
Net profit after tax |
136.1 |
182.0 |
+34% |
+48% |
|
|
|
|
|
|
|
Earning per share |
0,93 |
1,25 |
|
|
|
(*) Non-audited figures |
|
|
|
|
dsfsdgsxdf
| Source: UCB
Recommended Reading
-
CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders to the general meeting of the shareholders (the “General Meeting”) which will be held on...
Read More